Immune cells take on childhood leukemia: new trial launches
NCT ID NCT07406178
First seen Feb 14, 2026 · Last updated May 19, 2026 · Updated 14 times
Summary
This early-phase trial tests a new treatment called JY509 universal NK cell injection for children whose B-cell acute lymphoblastic leukemia has returned or not responded to standard therapy. About 18 children will receive the cells to see if it is safe and helps control the disease. The goal is to manage the leukemia, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY PEDIATRIC B-ALL are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.